What Survivors Need

Article

As this weekend's Cancer Survivorship Symposium, the discussion focused on what survivors need, when and with whom,

At this weekend's 2017 Cancer Survivorship Symposium, the discussion focused on what survivors need, when and with whom. The list of survivors’ follow-up needs is long, and, because cancer affects each person differently, distinct to the person and his or her cancer and treatment.

So where to start. The first thing a survivor needs when treatment ends is a Survivorship Care Plan. While this document should be begin with the day of diagnosis, it is currently given as an exit interview for the patient and gives all the details about the cancer and treatment, including date and stage of cancer at diagnosis and any details that may have affected treatment such as family, economic standing, etc. It looks at physical, emotional, and social needs, and, depending on the template, other issues such as employment.

Critical information on the plan is a listing of the drugs used in treatment and dosage because as time goes on, we are learning more information about late effects of drugs and/or radiation. For example, we know now that some drugs cause second cancers, and patients who had those drugs need to be followed closely. We know that radiation to certain parts of the body may diminish muscles and blood flow over time as atrophy occurs.

It is so logical that a patient would finish treatment with this document, and yet the vast majority don’t — in part because it is not offered. If this is the case for you, ask your oncologist to create one or print off an online template and do your own. There are multiple templates for care plans, but I recommend the one from Cancer.net, the website of the American Society for Clinical Oncology.

( http://www.cancer.net/survivorship/follow-care-after-cancer-treatment/asco-cancer-treatment-and-survivorship-care-plans)

Being followed after treatment, as you read in my last blog, can be confusing because the best professional may be at the cancer center or your primary care provider (PCP). Don’t assume your oncologist is going to be the best person, but he or she may be. It all depends on whether survivorship is part of his or her job. For most it isn’t, but if you were treated at a major cancer center, your oncologist should know who you need to see since it is now required that cancer centers have survivorship programs in place for accreditation. I actually found a PCP who was a cancer suvivor and we discussed our late effects and she researched areas where I asked for more information. But these discussions were usually started by me.

In cancer centers where they tell patients they have survivorship care offered, this could mean one or two support groups. In other centers, you will find cancer-specific clinics to follow you. You may also choose to be followed by your PCP, who may feel more logical to you since you may have had a long relationship before being diagnosed. But most PCPs are not yet trained in survivorship issues. They can follow you with respect to other issues at hand but may not be comfortable with survivorship follow up. Ask around. Ask your oncologist and your PCP who should follow you.

But no matter who will be following you, be sure you are followed for the possible long-term and late effects of the drugs and radiation you had for treatment.

Below is a list of the essential elements of follow-up care. These come from the American College of Physicians. The goals of survivorship care:

· Prevent recurrent and new cancers and other late effects

· Monitor for cancer spread or recurrence

· Assess medical and psychosocial late effects

· Manage consequences of cancer and its treatment

· Coordinate with other doctors, so all health needs are met

· Provide routine health promotion

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content